Ellen van der Spek

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study

Claudia A.M. Stege, Kazem Nasserinejad, Ellen van der Spek et al. · Journal of Clinical Oncology · 2021 · 60 citations · Full text

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Inger S. Nijhof, Laurens E. Franssen, Mark‐David Levin et al. · Blood · 2016 · 56 citations · Full text

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Moritz Fürstenau, Petra Langerbeins, Nisha De Silva et al. · Leukemia · 2020 · 45 citations · Full text

Clinical Infectious Disease, Covid-19 Pandemic, Immunology +7